For many years, the only FDA-approved iron chelator was Desferal , which has to be administered through a painful and difficult infusion process.

• 过去，地中海贫血患者并不进行频繁的输血，而临床研究则提倡更频繁的定期红血球输血，这极大地改善了患者的生活品质。